A phase III study comparing secondary long-term prophylaxis versus on-demand treatment with VWF/FVIII concentrates in patients with severe inherited von Willebrand disease and frequent bleeding episodes

被引：0
|
作者：
Castaman, Giancarlo [1 ]
Gresele, Paolo [2 ]
De Cristofaro, Raimondo [3 ]
Gagliano, Fabio [4 ]
Schinco, Piercarla [5 ]
Gamba, Gabriella [6 ]
Jimenez-Yuste, Victor [7 ]
Koenigs, Cristoph [8 ]
Federici, Augusto B. [9 ]
Peyvandi, Flora [10 ]
机构：
[1] Osped S Bortolo, Ctr Studio Malattie Emorrag & Trombot, Vicenza, Italy
[2] Azienda Osped Perugia, Perugia, Italy
[3] Univ Cattolica, Policlin A Gemelli, Ctr Riferimento Reg Malattie Emorrag, Rome, Italy
[4] Osped Bambini G di Cristina, Ctr Riferimento Reg Trombosi & Emostasi Pediat, Palermo, Italy
[5] Osped Molinette, Ctr Riferimento Reg Malattie Emorrag & Trombot Er, Turin, Italy
[6] Policlin San Matteo, Ctr Emofilia & Coagulopatie Congenite, Pavia, Italy
[7] Hosp Univ La Paz, Madrid, Spain
[8] Klinikum Johann Wolfgang Goethe Univ, Facharzt Kinder & Jugenmed, Frankfurt, Germany
[9] Univ Milan, L Sacco Univ Hosp, Dept Internal Med, Div Hematol & Transfus Med, Milan, Italy
[10] Univ Milan, Dept Pathophysiol & Transplantat, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Fdn IRCCS Ca Granda,Osped Maggiore Policlin, Milan, Italy
来源：
HAEMOPHILIA | 2018年 / 24卷
关键词：
D O I：
10.1484/J.HAM.5.115941
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
M-FPMED02-
引用
收藏
页码：106 / 106
页数：1
相关论文
共 14 条
  • [1] A phase III study comparing secondary long-term prophylaxis versus on-demand treatment with vWF/FVIII concentrates in severe inherited von Willebrand disease
    Peyvandi, Flora
    Castaman, Giancarlo
    Gresele, Paolo
    De Cristofaro, Raimondo
    Schinco, Piercarla
    Bertomoro, Antonella
    Morfini, Massino
    Gamba, Gabriella
    Barillari, Giovanni
    Jimenez-Yuste, Victor
    Koenigs, Cristoph
    Iorio, Alfonso
    Federici, Augusto B.
    BLOOD TRANSFUSION, 2019, 17 (05) : 391 - 398
  • [2] Cost-Effectiveness of Long-Term Prophylaxis Versus on-Demand Treatment with Von Willebrand Factor Concentrate in Severe Inherited Von Willebrand Disease
    Bhaskar, Anushka
    Connell, Nathan T.
    BLOOD, 2020, 136
  • [3] Effectiveness of long-term prophylaxis using pdFVIII/VWF concentrate in patients with inherited von Willebrand disease
    Rugeri, Lucia
    Harroche, Annie
    Repesse, Yohan
    Desprez, Dominique
    Petesch, Brigitte Pan
    Chamouni, Pierre
    Biron, Christine
    Frotscher, Birgit
    Catovic, Hasan
    Bracquart, Diane
    Martin, Cedric
    Trossaert, Marc
    Meunier, Sandrine
    d'Oiron, Roseline
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2022, 109 (01) : 109 - 117
  • [4] Secondary long-term prophylaxis in severe patients with von Willebrand's disease: An Italian cohort study.
    Federici, AB
    Gianniello, F
    Canciani, MT
    Mannucci, PM
    BLOOD, 2005, 106 (11) : 507A - 507A
  • [5] Analysis of joint bleeding events from a phase 3, multicenter, open-label study of on-demand recombinant von Willebrand factor (VWF) treatment in patients with severe von Willebrand disease (VWD)
    Windyga, J.
    Chojnowski, K.
    Pasi, J.
    Ploder, B.
    Mital, A.
    Berthoz, F. Truong
    Ewenstein, B.
    Mellgard, B.
    HAEMOPHILIA, 2019, 25 : 112 - 113
  • [6] Pharmacokinetics, efficacy, and safety of a plasma-derived VWF/FVIII concentrate (VONCENTO) for on-demand and prophylactic treatment in patients with von Willebrand disease (SWIFT-VWD study)
    Lissitchkov, Toshko J.
    Buevich, Evgeny
    Kuliczkowski, Kazimierz
    Stasyshyn, Oleksandra
    Cerqueira, Monica Hermida
    Klukowska, Anna
    Joch, Christine
    Seifert, Wilfried
    BLOOD COAGULATION & FIBRINOLYSIS, 2017, 28 (02) : 152 - 162
  • [7] Efficacy and safety of highly purified, doubly virus-inactivated VWF/FVIII concentrates in inherited von Willebrand's disease: results of an Italian cohort study on 120 patients characterized by bleeding severity score
    Federici, A. B.
    Barillari, G.
    Zanon, E.
    Mazzucconi, M. G.
    Musso, R.
    Targhetta, R.
    Mannucci, P. M.
    HAEMOPHILIA, 2010, 16 (01) : 101 - 110
  • [8] Current challenges in the diagnosis and management of patients with inherited von Willebrand's disease in Italy: an Expert Meeting Report on the diagnosis and surgical and secondary long-term prophylaxis
    Schinco, Piercarla
    Castaman, Giancarlo
    Coppola, Antonio
    Cultrere, Dorina
    Ettorre, Cosimo
    Giuffrida, Anna C.
    Marchesini, Emanuela
    Marino, Renato
    Milan, Marta
    Molinari, Claudio
    Siboni, Simona M.
    Zanon, Ezio
    Federici, Augusto B.
    BLOOD TRANSFUSION, 2018, 16 (04) : 371 - 381
  • [9] An Open-Label Extension Study to Assess the Long-Term Efficacy and Safety of a Plasma-Derived von Willebrand Factor (VWF)/Factor VIII (FVIII) Concentrate in Patients with von Willebrand Disease (SWIFT-VWDext Study)
    Lissitchkov, Toshko
    Klukowska, Anna
    Buevich, Evgeny
    Maltceva, Irina
    Auerswald, Guenter
    Stasyshyn, Oleksandra
    Seifert, Wilfried
    Rogosch, Tobias
    JOURNAL OF BLOOD MEDICINE, 2020, 11 : 345 - 356
  • [10] Use of the von Willebrand factor concentrate with low factor VIII content to manage patients with inherited von Willebrand disease requiring surgical or secondary long-term prophylaxis: An expert opinion paper from an Italian panel
    Castaman, Giancarlo
    Borchiellini, Alessandra
    Coppola, Antonio
    Cultrera, Dorina
    Marino, Renato
    Federici, Augusto B.
    Giuffrida, Anna Chiara
    Marchesini, Emanuela
    Molinari, Angelo Claudio
    Maria, Siboni Simona
    Zanon, Ezio
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2022, 109 (02) : 121 - 128
12